Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12

Published:2019-06-25 Issue:10 Volume:8 Page:4753-4765
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chi Xiaowei¹²³,Yang Peiwei¹²,Zhang Erhao¹²,Gu Jieyi¹²,Xu Hui¹²,Li Mengwei¹²,Gao Xinmei¹²,Li Xin¹²,Zhang Yinan¹²,Xu Hanmei¹²,Hu Jialiang¹²^ORCID

Affiliation:

1. The Engineering Research Center of Synthetic Polypeptide Drug Discovery and Evaluation of Jiangsu Province Nanjing P. R. China

2. State Key Laboratory of Natural Medicines, Ministry of Education China Pharmaceutical University Nanjing P. R. China

3. Development Center for Medicine Science and Technology National Health and Family Planning Commission of the People's Republic of China Beijing P. R. China

Funder

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2361

Reference38 articles.

1. Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies

2. CAR T-Cell Therapy in Large B-Cell Lymphoma

3. CAR T Cell Therapy for Solid Tumors

4. CAR T-Cell Therapies in Glioblastoma: A First Look

5. Microenvironmental regulation of therapeutic response in cancer

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered T cells for Colorectal Cancer;Immunotherapy;2024-09-04

2. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09

3. Advancements in combining targeted therapy and immunotherapy for colorectal cancer;Trends in Cancer;2024-07

4. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

5. Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity;Discover Oncology;2024-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3